Anti-Cancer Agent Developed at SBU Shows Great Promise Against Tumors, Receives $24M Investment

A second-generation taxane conjugate in a nanoemulsion formulation (called NE-DHA-SBT-1214) developed by Stony Brook University Distinguished Professor Iwao Ojima in his chemistry laboratory and through the Institute of Chemical Biology & Drug Discovery (ICB&DD) and licensed to Dr. James Egan, has received a $24 million investment to be taken to phase 2a development. Preclinical results have persuaded TVM Capital Life Science to invest in the technology via Recurv Pharma.

The VC fund will invest up to $24 million in Recurv through its project-focused company (PFC) investment objective, an initiative focused on backing first or best-in-class candidates that are clearly differentiated from the competition or add clinical value. Read More on Fierce Pharma and via SBU News.

Call for Applications-Spring 2023 Innovation Bootcamp

Long Island New York I-Corps Hub – Innovation Bootcamp Spring 2023 Program

This Innovation Bootcamp Program will teach scientists, inventors and first-time entrepreneurs the Lean Launchpad Methodology – Customer Discovery through 20 interviews, Agile Development roadmapping, and the Business Model Canvas – specifically Value Propositions and Customer Segments

Kickoff Session: Tuesday, February 14, 9:00 AM – 4:00 PM (Online)
Mid Session: Friday, February 14, 9:15 AM – 4:00 PM (Online) and
Finale Session: Friday, March 3, 9:15 AM – 3:00 PM (Room 109, R&D Park Research and Support Services)

Applications are being reviewed NOW on a rolling basis until 11:59 PM Friday, Feb 3, 2023. Limited space is available – apply early! https://forms.gle/RM8WRrN3VuGVCMgP8

Teams of 1+ faculty, staff, etc. from any university, national lab, or community teams with an Innovation or Research Idea should be STEAM focused are encouraged to apply. Must be able to attend all 3 scheduled workshops and dedicate time outside of the sessions to do customer discovery interviews
For full details and eligibility requirements, please visit https://tinyurl.com/SBUBootcampSpring23

SBU Student & CFB Fundamentals Program Alum
Wins NIH Pitch Competition

Christopher Ashdown, a Stony Brook University MD/PhD student and alumnus of the CFB’s Fundamentals of the Bioscience Industry Program, has won the Innovator Showcase Pitch Event at the 2022 Proof of Concept Network (POCN) Annual Meeting hosted by National Institutes of Health SEED (Small business Education and Entrepreneurial Development). Chris pitched on behalf of Lahara Bio.

Chris advanced through multiple rounds of pitching and was selected to present at the POCN Innovator Showcase with two other exceptional POCN innovators. Congratulations Chris!

Join us at io360! February 7-10 in Brooklyn NY

The 9th annual Immuno-Oncology 360° Summit, taking place February 7-10, 2023 in Brooklyn, NY, offers an unparalleled opportunity to hear from stakeholders representing both the science and business communities who report on the latest data impacting IO.

Center for Biotechnology constituents receive a 15% Discount on registration with code “CFB15”

Learn more at www.IO360Summit.com

CFB Advisor Named Top 25 Women In Biotech

CFB Advisor and Long Island BioMentor Initiative Founding Mentor Kara Canon was names one of the Top 25 Women Leaders in Biotechnology of 2022 according to The Healthcare Technology Report. Kara Cannon is Chief Operating Officer of Enzo Biochem, Inc and has been working with this leading biosciences and diagnostics company for over 12 years. She has been an advisor to the Center for Biotechnology and in 2016 became one of the founding mentors of the Long Island BioMentor Initiative. View the full list and read about all the amazing women to make the list here.